Applied DNA Sciences, Inc. APDN Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2013 at 3:06 PM

Applied DNA Sciences, Inc. APDN Company Overview

Stock Message Board http://investorshangout.com/search?q=APDN&type=1&yt1=Go!

Applied DNA Sciences, Inc. APDN Current Price and Quotes
Last Price 0.115
Previous Close 0.122 Open 0.1225
Daily Range 0.125 - 0.111 52wk Range 0.305 - 0.111
Volume 4,580,883 Dividend N/A
Average Vol (3m) 2,582,949 Yield N/A
Applied DNA Sciences, Inc. APDN
Company Information

50 Health Sciences Drive
Stony Brook, NY 11790

Website: http://www.adnas.com
Phone: 631-240-8800
Email: info@adnas.com

Applied DNA Sciences, Inc. APDN
Applied DNA Sciences (APDN) is the only company in the world that is making use of the complex codes embedded in botanical DNA as the ultimate solution to counterfeiting, supply chain defense, perpetrator marking, tactical forensic systems, and a growing range of other unbreakable authentication programs.

Applied DNA Sciences, Inc. APDN
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000744452
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2860 - Industrial Organic Chemicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 21 a/o Sep 30, 2011
Company Officers/Contacts

James A. Hayward CEO
Benjamin Liang CTO
Company Directors

Gerald Catenacci
Karol Gray
John Bitzer, III
Charles Ryan
Yacov Shamash
Sanford Simon
Company Notes

Formerly=ProHealth Medical Technologies, Inc. until 11-02
Formerly=Datalink Capital Corp. until 11-99
Note=9-30-04 company is in the development stage
Service Providers

Auditor/Accountant
RBSM LLP
805 Third Avenue
Suite 902
New York, NY, 10022
United States

Legal Counsel
Fulbright and Jaworski
666 Fifth Avenue
New York, NY, 10103
United States

Investor Relations Firm
Not Available

Applied DNA Sciences, Inc. APDN
APDN Security Details

Share Structure

Market Value1 $90,794,750 a/o Sep 20, 2013
Shares Outstanding 744,219,263 a/o Aug 08, 2013
Float Not Available
Authorized Shares 1,350,000,000 a/o Jan 27, 2012
Par Value 0.001
Shareholders

Shareholders of Record 5,245 a/o Dec 20, 2012
Security Notes

Par Changed=50 Cents from $0.0001, effective date 12-12-03. Basis: amendment to Articles of Incorporation
Capital Change=shs decreased by 1 for 10 split. Pay date=11/01/1999.
Short Selling Data

Short Interest 10,365,641 (0.86%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Applied DNA Sciences, Inc. APDN Recent News

Sept 19, 2013 Applied DNA Sciences to Present Anti-Counterfeiting Proposal at SAE Symposium, September 27
Sept 12, 2013 Applied DNA Sciences and Prime Contractor L-3 Power Paragon Sign Agreement for SigNature DNA Marking in Support of DLA Effort
Sept 6, 2013 OTC Signal Daily Stock Watch - Applied DNA Sciences (OTCQB: APDN)
Aug 22, 2013 Lintech Components Receives Signature DNA Marker Certificate From Applied DNA Sciences
Aug 21, 2013 Applied DNA Sciences Appoints Karol Kain Gray as Chief Financial Officer
Aug 13, 2013 Applied DNA Sciences Reports Fiscal Third Quarter 2013 Results Highest Quarterly Revenues
Aug 8, 2013 Applied DNA Sciences to Host Conference Call Thursday, August 15, 2013
Aug 6, 2013 Applied DNA Sciences: SigNature DNA(R)-Marking Against Counterfeits Is "Prime-Contractor and Manufacturer-Ready"
Aug 2, 2013 Nearly Half-Million SigNature DNA-Marked Electronic Components in Circulation
Jul 26, 2013 OTC Daily Alert Stock Watch

1
2
next >

Applied DNA Sciences, Inc. APDN Financials
Period Ending Sep 30, 2012 Sep 30, 2011 Sep 30, 2010 Sep 30, 2009
Total Revenue 1,855 969 520 295
Cost of Revenue - - - 61
Gross Profit 1,855 969 520 234
Operating Expenses

Research and Development 433 269 76 135
Sales, General and Admin. 7,616 8,389 7,189 6,576
Non-Recurring Items - - - -
Other 314 368 372 418
Operating Income (6,508) (8,056) (7,117) (6,896)
Income From Continuing Operations

Add'l Income/Expense Items - - - 12,024
Earnings Before Interest and Tax (6,508) (8,056) (7,910) 3,945
Interest Expense 643 2,459 - -
Earnings Before Tax (7,151) (10,515) (7,910) 3,945
Income Tax - - - 1
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,151) (10,515) (7,910) 3,945
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,151) (10,515) (7,910) 3,945
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,151) (10,515) (7,910) 3,945

APDN Applied DNA Sciences, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=APDN&type=1&yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/APDN/quote
Stock Chart http://www.otcmarkets.com/stock/APDN/chart
Company Info http://www.otcmarkets.com/stock/APDN/company-info
Recent News http://www.otcmarkets.com/stock/APDN/news
Financials http://www.otcmarkets.com/stock/APDN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/APDN/filings
Short Sales http://www.otcmarkets.com/stock/APDN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/APDN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/APDN/research
Summary http://finance.yahoo.com/q?s=APDN
Historical Prices http://finance.yahoo.com/q/hp?s=APDN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=APDN
Basic Chart http://finance.yahoo.com/q/bc?s=APDN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=APDN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=APDN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=APDN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=APDN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=APDN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=APDN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=APDN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=APDN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=APDN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=APDN
Balance Sheet http://finance.yahoo.com/q/bs?s=APDN
Cash Flow http://finance.yahoo.com/q/cf?s=APDN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/APDN
Market Watch http://www.marketwatch.com/investing/stock/APDN
Bloomberg http://www.bloomberg.com/quote/APDN:US
Morningstar http://quotes.morningstar.com/stock/s?t=APDN
Bussinessweek http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=APDN
Barchart http://www.barchart.com/quotes/stocks/APDN
OTC Short Report http://otcshortreport.com/index.php?index=APDN
Investopedia http://www.investopedia.com/markets/stocks/APDN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...